Mechanistic links between mutations in the CLPB gene and congenital neutropenia

CLPB基因突变与先天性中性粒细胞减少症之间的机制联系

基本信息

  • 批准号:
    10526864
  • 负责人:
  • 金额:
    $ 24.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Hereditary biallelic mutations in the CLPB gene are the cause of congenital neutropenia associated with MEGCANN, a rare autosomal recessive disease (OMIM entry #616271). In its severe form, the disease leads to death by a few months of age as a result of significant neurologic symptoms or life-threatening infections. Recently identified de novo monoallelic mutations in the CLPB gene act in a dominant-negative manner and also cause severe congenital neutropenia. The CLPB gene encodes a broadly expressed mitochondrial protein containing several ankyrin repeats and a single AAA+ (ATPases Associated with diverse cellular Activities) module. The molecular mechanism of CLPB function in neutrophil precursor cells is not known, and the mitochondrial defects elicited by mutated CLPB variants and their link to defective granulopoiesis are poorly defined. We hypothesize that CLPB is essential for the metabolic shift from glycolysis to mitochondrial respiration during neutrophil differentiation. We will test this hypothesis by completing two Specific Aims. In Aim 1, we will determine the role of CLPB in mitochondrial morphology, metabolism, and neutrophil differentiation using myeloblastic cell line models of granulopoiesis. This Aim will test the sub-hypothesis that CLPB plays an essential role in mitochondrial remodeling and metabolic reprogramming during neutrophil differentiation. In Aim 2, we will examine the effect of disease mutations on the interactions between CLPB and key regulators of mitochondrial dynamics and cristae morphology. This Aim will test the sub- hypothesis that the principal difference between the effects of biallelic vs. monoallelic mutations on the CLPB activity arises from distinct interaction propensities of the mutated CLPB variants. At the outcome, our studies will provide a new insight into the role of CLPB in neutrophil differentiation, will help understand the molecular defects of the disease CLPB variants, and will set the stage for developing potential treatments for neutropenias caused by CLPB mutations.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anna Zolkiewska其他文献

Anna Zolkiewska的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anna Zolkiewska', 18)}}的其他基金

Mechanistic links between mutations in the CLPB gene and congenital neutropenia
CLPB基因突变与先天性中性粒细胞减少症之间的机制联系
  • 批准号:
    10630259
  • 财政年份:
    2022
  • 资助金额:
    $ 24.25万
  • 项目类别:
ADAM12 in Breast Tumor Initiating Cells
乳腺肿瘤起始细胞中的 ADAM12
  • 批准号:
    8419763
  • 财政年份:
    2013
  • 资助金额:
    $ 24.25万
  • 项目类别:
ADAM12 in Breast Tumor Initiating Cells
乳腺肿瘤起始细胞中的 ADAM12
  • 批准号:
    8792604
  • 财政年份:
    2013
  • 资助金额:
    $ 24.25万
  • 项目类别:
ADAM12 in Breast Tumor Initiating Cells
乳腺肿瘤起始细胞中的 ADAM12
  • 批准号:
    8607521
  • 财政年份:
    2013
  • 资助金额:
    $ 24.25万
  • 项目类别:
Structure-Function Analysis of Breast Cancer-Associated Mutations in ADAM12
ADAM12 中乳腺癌相关突变的结构功能分析
  • 批准号:
    7940388
  • 财政年份:
    2010
  • 资助金额:
    $ 24.25万
  • 项目类别:
Molecular Analysis of Metalloprotease Disintegrin ADAM12
金属蛋白酶解整合素 ADAM12 的分子分析
  • 批准号:
    6773709
  • 财政年份:
    2004
  • 资助金额:
    $ 24.25万
  • 项目类别:
COBRE: U KS: P6: STRUCTURE AND FUNCTION OF CELL ADHESION DOMAIN OF ADAM12
COBRE:UK KS:P6:ADAM12 细胞粘附域的结构和功能
  • 批准号:
    6981854
  • 财政年份:
    2004
  • 资助金额:
    $ 24.25万
  • 项目类别:
Molecular Analysis of Metalloprotease Disintegrin ADAM12
金属蛋白酶解整合素 ADAM12 的分子分析
  • 批准号:
    6873698
  • 财政年份:
    2004
  • 资助金额:
    $ 24.25万
  • 项目类别:
Molecular Analysis of Metalloprotease Disintegrin ADAM12
金属蛋白酶解整合素 ADAM12 的分子分析
  • 批准号:
    7209772
  • 财政年份:
    2004
  • 资助金额:
    $ 24.25万
  • 项目类别:
Molecular Analysis of Metalloprotease Disintegrin ADAM12
金属蛋白酶解整合素 ADAM12 的分子分析
  • 批准号:
    7031567
  • 财政年份:
    2004
  • 资助金额:
    $ 24.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了